Press Releases

Date Title and Summary Additional Formats
Toggle Summary CHF Solutions, Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market
EDEN PRAIRIE, Minn. , March 30, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced the pricing of a registered direct offering of 5,130,228 shares of its common stock at a price to the public of $0.434 per share, for gross proceeds of approximately $2,226,000 , prior to deduction
View HTML
Toggle Summary CHF Solutions Announces COVID-19 Patients Treated with Aquadex Therapy for Fluid Management
Company increases production in response to expected demand EDEN PRAIRIE, Minn. , March 25, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced the use of its Aquadex therapy in the
View HTML
Toggle Summary CHF Solutions, Inc. Announces Pricing of Registered Direct Offering
EDEN PRAIRIE, Minn. , March 20, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced the pricing of a registered direct offering of 4,161,392 shares of its common stock at a price to the public of $0.30 per share, for gross proceeds of approximately $1,248,000 , prior to deduction
View HTML
Toggle Summary CHF Solutions’ Aquadex FlexFlow® System is licensed and approved for sale in India
EDEN PRAIRIE, Minn. , March 19, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced the Aquadex FlexFlow system has been licensed and approved for sale in India , making ultrafiltration therapy available for patients suffering from hypervolemia, or fluid overload, in one of the
View HTML
Toggle Summary CHF Solutions Webinar Highlighted Importance of Fluid Management in Patients Treated for COVID-19
Proper Control of Fluids Routinely Administered to Patients with Acute Respiratory Infections Play Important Role in Successful Outcomes EDEN PRAIRIE, Minn. , March 18, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients
View HTML
Toggle Summary CHF Solutions to Host Clinician Webinar on Use of Ultrafiltration for Volume Management in Patients Treated for COVID-19
EDEN PRAIRIE, Minn. , March 13, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced the company will host an interactive, physician-led webinar to discuss the importance of volume management in the treatment of patients with COVID-19.  Dr.
View HTML
Toggle Summary CHF Solutions, Inc. Announces Fourth Quarter Financial Results and Provides Company Update
EDEN PRAIRIE, Minn. , March 03, 2020 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the fourth quarter and year ended December 31, 2019 , which included the following highlights: Received 510(k) clearance in the U.S.
View HTML
Toggle Summary CHF Solutions receives 510(k) clearance for Aquadex SmartFlow™ system in Pediatric Patients Weighing 20kg or More
EDEN PRAIRIE, Minn. , Feb. 26, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced FDA 510(k) clearance in the U.S. of its next generation Aquadex SmartFlow console for use in adult and pediatric patients who weigh 20kg or more. The console is a simple, gentle, and smart solution
View HTML
Toggle Summary CHF Solutions, Inc. To Announce Fourth Quarter and Year-End 2019 Financial Results on March 3, 2020
EDEN PRAIRIE, Minn. , Feb. 25, 2020 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its fourth quarter and year-end 2019 financial results will be released on Tuesday, March 3, 2020 . The company will host a conference call and webcast at 9:00 AM ET that morning, during
View HTML
Toggle Summary CHF Solutions Expands Commercial Presence in Europe with Distribution Arrangement for Germany, Austria and Switzerland
EDEN PRAIRIE, Minn. , Feb. 12, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced the initiation of distribution agreements covering Germany , Austria and Switzerland with Neucomed Group and its affiliates, further expanding its commercial presence in the European Union .
View HTML